Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Novo Nordisk’s semaglutide obesity trial hits the mark

Novo Nordisk’s semaglutide obesity trial hits the mark

The positive data in obesity is another boost for Novo as it tries to position semaglutide as a successor to Victoza, which pulled in $3.8bn in sales for the Danish ... Victoza’s patents are also being challenged by generic rivals - including Teva in

Takeda and Zinfandel abandon Alzheimer’s drug

Takeda and Zinfandel abandon Alzheimer’s drug Meanwhile, other diabetes drugs have also been tested for activity in AD, including Novo Nordisk's Victoza (liraglutide) which seemed to reduce amyloid plaque formation but had no effect on cognitive

Novo Nordisk gets FDA nod for once-weekly rival to Lilly’s Trulicity

Novo Nordisk gets FDA nod for once-weekly rival to Lilly’s Trulicity of the year mainly because of its dosing advantage versus daily GLP-1 drugs like Novo’s Victoza (liraglutide).

J&J seeks US OK to add CV claim to Invokana label

J&J seeks US OK to add CV claim to Invokana label If approved the treatment could better compete with rivals Jardiance and Victoza. ... label in the wake of the EMPA-REG study, as well as Novo Nordisk’s GLP-1 agonist Victoza (liraglutide) which was given a cardiovascular disease reduction indication

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics